Prognostic value of CD144 positive endothelium-derived-microparticles (CD144-EMP) in patients with heart failure

Prognostic value of CD144 positive endothelium-derived-microparticles (CD144-EMP) in patients with heart failure - Prognostic value of endothelial microparticles in patients with heart failure

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000002117

Enrollment

300

Registered

2009-07-30

Start date

2003-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Japanese patinets with heart failure

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Stage B or more at classification assessed by ACC/AHA guideline

Exclusion criteria

Exclusion criteria: The exclusion criteria for the study were severe valvular heart disease requiring surgical intervention within one month, active infection, malignant disease, and acute coronary syndrome.

Design outcomes

Primary

Measure	Time frame
Heart failure events (re-hospitalization for HF, valvular operation, or cardiovascular death).	—

Countries

Japan

Outcome results